Services
This voting program aims to establish data on sustainable development, helping the government and relevant social organizations to formulate policies based on reality to support businesses in sustainable development. Thus, together with a Vietnam that is committed to the goals at COP26 to reduce net emissions to zero by 2050; affirming the continuation of activities to respond to climate change, especially in the development of clean energy, sustainable infrastructure, smart water management, and resources within the ecosystem.
 Mr. Nguyen An Duy (center), Deputy General Director of Finance at Imexpharm, represented the company in receiving the Top 50 Sustainable Development Enterprise Award organized by Nhip Cau Dau Tu Magazine in Ho Chi Minh City on August 2, 2024. Photo: Imexpharm
|
With 14 voting categories based on the 3 ESG pillars (Environment – Society – Governance), the program recognizes and honors enterprises, including FDI, listed, and unlisted companies, that have contributed to sustainable, environmentally friendly, and socially equitable development.
As a listed pharmaceutical company with a high market capitalization in the industry, Imexpharm has effectively implemented a sustainable development model in the pharmaceutical industry. From its early days, Imexpharm has aimed for sustainable development for the community’s well-being. With this orientation, Imexpharm has become the pharmaceutical company with the largest EU-GMP factory cluster in Vietnam, with 3 EU-GMP factory clusters and 11 EU-GMP production lines. Thanks to its early investment in high-quality production technology, Imexpharm has maintained continuous growth and is Vietnam’s number one in antibiotic medication.
Imexpharm currently possesses a leading competitive advantage over domestic pharmaceutical companies through its strategy of building factories that meet EU-GMP standards and investing heavily in research and development (R&D). The company is leading the trend in investing in EU-GMP standard factories and is well-prepared for a golden development period with its four factories producing medicine according to international quality standards.
Mr. Nguyen An Duy stated that the award greatly encourages Imexpharm to continue pursuing sustainable development goals for the community’s well-being. Photo: Imexpharm
|
“We recognize that practicing sustainable development goals will help our company continue to grow by providing the market with Vietnamese medicines under the Imexpharm brand that meet European quality standards,” said People’s Teacher – Pharmacist Tran Thi Dao, General Director of Imexpharm.
The healthcare sector and pharmaceutical companies play a crucial role in achieving the United Nations Sustainable Development Goals (UN SDGs), bringing prosperity to the community. In line with the aspiration to take the enterprise to new heights, Imexpharm’s message, “Sharing for Sustainability,” is built on a foundation of tradition, a long-term vision, and a sustainable development strategy based on five main pillars: People, Living Environment, Prosperity, Cooperation, and Building a Strong and Caring Organization.
With its extensive sustainable practices, Imexpharm has achieved notable accomplishments in environmental protection, such as energy conservation, medical waste treatment, and tree planting. All of Imexpharm’s factories now have initial wastewater treatment systems that meet stringent standards. Here, all wastewater is treated through a wastewater treatment system that ensures compliance with ISO 14001:2015 standards before being discharged into the environment. In terms of social responsibility, the company consistently fulfills its obligations to society and the community by providing stable and sustainable employment, contributing to local economic development, fulfilling tax obligations to the state, and organizing and participating in programs for social welfare.
The award also recognizes Imexpharm’s outstanding achievements in environmental protection, including energy conservation, medical waste treatment, and tree planting. Photo: Imexpharm
|
“ESG investment is an opportunity to demonstrate the company’s vision and mission in addressing community issues. This foundation has enabled us to promote sustainable practices and, in turn, encourage innovation and operational and business efficiency in line with international models,” said the General Director of Imexpharm.
The Advantages of Saint-Gobain in the “Green Racing” Track
Pioneering early investments in the production and supply of lightweight, sustainable construction materials, Saint-Gobain has achieved success and is ready to expand its ecosystem of these solutions to meet the potential market demand in Vietnam.
